OncRef

Clinical Trial: NCT06952920

Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer

Status:

RECRUITING

Phase:

Phase 3

Lead Sponsor:Jiuda Zhao
Information Provided By:Affiliated Hospital of Qinghai University
Last Update Posted:2026-07-10

Study Overview

Brief Summary

This study aims to elucidate the therapeutic efficacy of electroacupuncture in managing chemotherapy-induced gastrointestinal symptom clusters through clinical research. Building upon this foundation, multi-omics analyses will be conducted to investigate the regulatory effects and underlying mechanisms of electroacupuncture on gastrointestinal symptoms. Ultimately, genomic studies will be performed to further clarify the key targets of electroacupuncture intervention, thereby providing high-level evidence-based medical support and theoretical foundations for optimizing electroacupuncture strategies in addressing chemotherapy-induced gastrointestinal symptoms in patients with cancer.

Official Title

Electroacupuncture for Managing Chemotherapy-Induced Gastrointestinal Symptom Clusters in Patients With Breast Cancer

Conditions

Standard Quadruple Antiemetic Therapy, Electroacupuncture, Chemotherapy-induced Gastrointestinal Symptom Cluster

Intervention / Treatment

  • Device: electroacupuncture
  • Drug: standard quadruple antiemetic therapy
  • Device: sham electroacupuncture
  • Drug: standard quadruple antiemetic therapy

Other Study ID Numbers

  • AHQU-2025002

Start Date (Actual)

2025-08-21

Primary Completion Date (Estimated)

2028-06-30

Study Completion Date (Estimated)

2028-06-30

Enrollment (Estimated)

388

Study Type

Interventional

Phase

Phase 3